These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 28915803)

  • 41. CD44 cross-linking induces integrin-mediated adhesion and transendothelial migration in breast cancer cell line by up-regulation of LFA-1 (alpha L beta2) and VLA-4 (alpha4beta1).
    Wang HS; Hung Y; Su CH; Peng ST; Guo YJ; Lai MC; Liu CY; Hsu JW
    Exp Cell Res; 2005 Mar; 304(1):116-26. PubMed ID: 15707579
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CD44 activation state regulated by the CD44v10 isoform determines breast cancer proliferation.
    Guo Q; Liu Y; He Y; Du Y; Zhang G; Yang C; Gao F
    Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649828
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of a new CD44st in increasing the invasion capability of the human breast cancer cell line MCF-7.
    Fang XJ; Jiang H; Zhao XP; Jiang WM
    BMC Cancer; 2011 Jul; 11():290. PubMed ID: 21749678
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Regulation of CD44 expression and focal adhesion by Golgi phosphatidylinositol 4-phosphate in breast cancer.
    Ijuin T; Takeuchi Y; Shimono Y; Fukumoto M; Tokuda E; Takenawa T
    Cancer Sci; 2016 Jul; 107(7):981-90. PubMed ID: 27178239
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genetic and small molecule inhibition of arylamine N-acetyltransferase 1 reduces anchorage-independent growth in human breast cancer cell line MDA-MB-231.
    Stepp MW; Doll MA; Carlisle SM; States JC; Hein DW
    Mol Carcinog; 2018 Apr; 57(4):549-558. PubMed ID: 29315819
    [TBL] [Abstract][Full Text] [Related]  

  • 47. YBX1 gene silencing inhibits migratory and invasive potential via CORO1C in breast cancer in vitro.
    Lim JP; Shyamasundar S; Gunaratne J; Scully OJ; Matsumoto K; Bay BH
    BMC Cancer; 2017 Mar; 17(1):201. PubMed ID: 28302118
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Proteomics analysis reveals the role of ubiquitin specific protease (USP47) in Epithelial to Mesenchymal Transition (EMT) induced by TGFβ2 in breast cells.
    Silvestrini VC; Thomé CH; Albuquerque D; de Souza Palma C; Ferreira GA; Lanfredi GP; Masson AP; Delsin LEA; Ferreira FU; de Souza FC; de Godoy LMF; Aquino A; Carrilho E; Panepucci RA; Covas DT; Faça VM
    J Proteomics; 2020 May; 219():103734. PubMed ID: 32201364
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Simvastatin prevents skeletal metastasis of breast cancer by an antagonistic interplay between p53 and CD44.
    Mandal CC; Ghosh-Choudhury N; Yoneda T; Choudhury GG; Ghosh-Choudhury N
    J Biol Chem; 2011 Apr; 286(13):11314-27. PubMed ID: 21199873
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Calycosin inhibits triple-negative breast cancer progression through down-regulation of the novel estrogen receptor-α splice variant ER-α30-mediated PI3K/AKT signaling pathway.
    Li Y; Hu S; Chen Y; Zhang X; Gao H; Tian J; Chen J
    Phytomedicine; 2023 Sep; 118():154924. PubMed ID: 37393829
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Osteoclast migration on phosphorylated osteopontin is regulated by endogenous tartrate-resistant acid phosphatase.
    Ek-Rylander B; Andersson G
    Exp Cell Res; 2010 Feb; 316(3):443-51. PubMed ID: 19854170
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CD44 alternative splicing and hnRNP A1 expression are associated with the metastasis of breast cancer.
    Loh TJ; Moon H; Cho S; Jang H; Liu YC; Tai H; Jung DW; Williams DR; Kim HR; Shin MG; Liao DJ; Zhou J; Shi W; Zheng X; Shen H
    Oncol Rep; 2015 Sep; 34(3):1231-8. PubMed ID: 26151392
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Involvement of the ERK/HIF-1α/EMT Pathway in XCL1-Induced Migration of MDA-MB-231 and SK-BR-3 Breast Cancer Cells.
    Do HTT; Cho J
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374849
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer.
    Chang XZ; Li DQ; Hou YF; Wu J; Lu JS; Di GH; Jin W; Ou ZL; Shen ZZ; Shao ZM
    Breast Cancer Res; 2007; 9(6):R76. PubMed ID: 17980029
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cortactin underpins CD44-promoted invasion and adhesion of breast cancer cells to bone marrow endothelial cells.
    Hill A; McFarlane S; Mulligan K; Gillespie H; Draffin JE; Trimble A; Ouhtit A; Johnston PG; Harkin DP; McCormick D; Waugh DJ
    Oncogene; 2006 Oct; 25(45):6079-91. PubMed ID: 16652145
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High-throughput RNAi screening for novel modulators of vimentin expression identifies MTHFD2 as a regulator of breast cancer cell migration and invasion.
    Lehtinen L; Ketola K; Mäkelä R; Mpindi JP; Viitala M; Kallioniemi O; Iljin K
    Oncotarget; 2013 Jan; 4(1):48-63. PubMed ID: 23295955
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The action of hyaluronan in functional properties, morphology and expression of matrix effectors in mammary cancer cells depends on its molecular size.
    Tavianatou AG; Piperigkou Z; Koutsakis C; Barbera C; Beninatto R; Franchi M; Karamanos NK
    FEBS J; 2021 Jul; 288(14):4291-4310. PubMed ID: 33512780
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Targeting CD44-STAT3 signaling by Gemini vitamin D analog leads to inhibition of invasion in basal-like breast cancer.
    So JY; Smolarek AK; Salerno DM; Maehr H; Uskokovic M; Liu F; Suh N
    PLoS One; 2013; 8(1):e54020. PubMed ID: 23326564
    [TBL] [Abstract][Full Text] [Related]  

  • 59. JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer.
    Lee YF; Miller LD; Chan XB; Black MA; Pang B; Ong CW; Salto-Tellez M; Liu ET; Desai KV
    Breast Cancer Res; 2012 May; 14(3):R85. PubMed ID: 22621393
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rac3 induces a molecular pathway triggering breast cancer cell aggressiveness: differences in MDA-MB-231 and MCF-7 breast cancer cell lines.
    Gest C; Joimel U; Huang L; Pritchard LL; Petit A; Dulong C; Buquet C; Hu CQ; Mirshahi P; Laurent M; Fauvel-Lafève F; Cazin L; Vannier JP; Lu H; Soria J; Li H; Varin R; Soria C
    BMC Cancer; 2013 Feb; 13():63. PubMed ID: 23388133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.